BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Ketozip 200 XL capsules 1001010L0BKAAAJ	Ketozip	Ketoprofen	Musculoskeletal and Joint Diseases	No data available
Ketpron XL 100mg capsules 1001010L0BPAAAI	Ketpron	Ketoprofen	Musculoskeletal and Joint Diseases	No data available
Ketpron XL 200mg capsules 1001010L0BPABAJ	Ketpron	Ketoprofen	Musculoskeletal and Joint Diseases	No data available
Ketur Test testing strips 0601060U0BJAAA0	Ketur (Reagent)	Urine testing reagents	Endocrine System	No data available
Kevesy 1.5g/100ml infusion bags 0408010A0BFACAR	Kevesy	Levetiracetam	Central Nervous System	No data available
Kevesy 1g/100ml infusion bags 0408010A0BFABAQ	Kevesy	Levetiracetam	Central Nervous System	No data available
Kevesy 500mg/100ml infusion bags 0408010A0BFAAAP	Kevesy	Levetiracetam	Central Nervous System	No data available
Kevzara 150mg/1.14ml inj pre-filled syringes 1001030ADBBAAAA	Kevzara	Sarilumab	Musculoskeletal and Joint Diseases	No data available
Kevzara 150mg/1.14ml solution for injection pre-filled pens 1001030ADBBACAC	Kevzara	Sarilumab	Musculoskeletal and Joint Diseases	No data available
Kevzara 200mg/1.14ml inj pre-filled syringes 1001030ADBBABAB	Kevzara	Sarilumab	Musculoskeletal and Joint Diseases	No data available
Kevzara 200mg/1.14ml solution for injection pre-filled pens 1001030ADBBADAD	Kevzara	Sarilumab	Musculoskeletal and Joint Diseases	No data available
Keyhole dressing for washout set 23703757007	Keyhole dressing for washout set	Irrigation Washout Appliances	Stoma Appliances	No data available
Keytruda 100mg/4ml concentrate for inf vials 0801050CABBABAB	Keytruda	Pembrolizumab	Malignant Disease and Immunosuppression	No data available
Keytruda 50mg pdr for concentrate for inf vials 0801050CABBAAAA	Keytruda	Pembrolizumab	Malignant Disease and Immunosuppression	No data available
Kigabeq 100mg soluble tablets 0408010X0BCAABL	Kigabeq	Vigabatrin	Central Nervous System	No data available
Kigabeq 500mg soluble tablets 0408010X0BCABBM	Kigabeq	Vigabatrin	Central Nervous System	No data available
Kilkof lozenges 120303000BBBZA0	Proprietary compound preparation BNF 1203030	Other lozenge and spray preparations	Ear, Nose and Oropharynx	No data available
Kilkof oral solution 030902000BEDKA0	Proprietary compound preparation BNF 0309020	Other expectorantand demulcent cough preparations	Respiratory System	No data available
Kineret 100mg/0.67ml inj pre-filled syringes 1001030R0BBAAAA	Kineret	Anakinra	Musculoskeletal and Joint Diseases	No data available
Kinerva Daily Vitality capsules 091104000BBPKBF	Proprietary compound preparation BNF 0911040	Other digestive aid preparations	Nutrition and Blood	No data available
Kinidin 250mg Durules 0203020T0BCAAAB	Kinidin Durule	Quinidine bisulfate	Cardiovascular System	No data available
Kiovig 10g/100ml solution for infusion vials 1405010A0BVADBQ	Kiovig	Normal immunoglobulin (Gamma globulin)	Immunological Products and Vaccines	No data available
Kiovig 1g/10ml solution for infusion vials 1405010A0BVAABU	Kiovig	Normal immunoglobulin (Gamma globulin)	Immunological Products and Vaccines	No data available
Kiovig 2.5g/25ml solution for infusion vials 1405010A0BVABBS	Kiovig	Normal immunoglobulin (Gamma globulin)	Immunological Products and Vaccines	No data available
Kiovig 20g/200ml solution for infusion vials 1405010A0BVAEBR	Kiovig	Normal immunoglobulin (Gamma globulin)	Immunological Products and Vaccines	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.